Munafa Stock Market Course + Intraday & FNO calls 
SPARC NEWS why is Sun Pharma Advanced Research Company Limited price falling or rising
SPARC NEWS reasons for why stock price of Sun Pharma Advanced Research Company Limited is falling or rising
SPARC Sun Pharma is falling or rising technical reasons
Technical analysis forecast of Sun Pharma Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Sun Pharma SPARC at this time. Stock is rising and might rise more.
It appears as if Sun Pharma SPARC gave a large move recently.
Stock of Sun Pharma (SPARC) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Sun Pharma is bullish for shortterm, and stock might move up till 218.5 or till 246.4. Use a stoploss of 195.37 and if this stock hits its stoploss, then it can fall down till 172.19
SPARC Sun Pharma is falling or rising NEWS fundamental reasons
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun Pharma The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medication, Bevatas, to the market. This decision overturns a previous block on the drug, affirming the court's view that Bev - NEWS as on 2026-06-02 indiatimes.com
Sun Pharmaceutical Industries Share Price Live Updates: Filing Of Application For Reclassification With Stock Exchanges - NEWS as on 2026-05-27 indiatimes.com
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding 'Statutory Auditor's Certificate in terms of Regulation 169(5) of SEBI ICDR Regulations'. - NEWS as on 2026-05-26
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore reported in the October-December quarter of FY26. - NEWS as on 2026-05-22 indiatimes.com
Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments Bank Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to continue its consolidation between 23,200 and 23,900. Several companies, including ITC, LIC, Sun Pharma, Maruti Suzuki - NEWS as on 2026-05-22 indiatimes.com
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter? Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady ma - NEWS as on 2026-05-21 indiatimes.com
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about PDP-716 NDA Update - NEWS as on 2026-05-20
Company Announcement Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the financial results for the quarter and financial year ended March 31, 2026. - NEWS as on 2026-05-19
Board Meeting to discuss Financial Results To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026 - NEWS as on 2026-05-12
Company Announcement - NEWS as on 2026-05-12
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated April 30, 2026, titled "SPARC Announces Sale of Priority Review Voucher for US 5 million". - NEWS as on 2026-04-30
Company Announcement Dilip S. Shanghvi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. - NEWS as on 2026-04-13
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 - NEWS as on 2026-04-07
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about Change in Management - NEWS as on 2026-03-30
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2026-03-27
More announcements and NEWS
SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals
Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 08 Mon Jun 2026 | 203.60 | 201.10 to 214.17 | -4.33% | 0.13 times |
| 05 Fri Jun 2026 | 212.82 | 210.90 to 222.59 | -0.07% | 0.21 times |
| 04 Thu Jun 2026 | 212.97 | 205.01 to 215.79 | 2.14% | 0.19 times |
| 03 Wed Jun 2026 | 208.50 | 196.50 to 210.59 | 2.09% | 0.28 times |
| 02 Tue Jun 2026 | 204.24 | 194.10 to 207.38 | 4.01% | 0.41 times |
| 01 Mon Jun 2026 | 196.37 | 195.45 to 215.37 | -7.42% | 0.37 times |
| 29 Fri May 2026 | 212.11 | 210.55 to 224.50 | -4.17% | 0.29 times |
| 27 Wed May 2026 | 221.35 | 213.01 to 233.50 | -6.04% | 0.64 times |
| 26 Tue May 2026 | 235.57 | 231.00 to 248.75 | 1.11% | 2.18 times |
| 25 Mon May 2026 | 232.99 | 212.00 to 239.40 | 11.07% | 3.54 times |
| 22 Fri May 2026 | 209.77 | 179.82 to 214.00 | 16.33% | 1.88 times |
| 21 Thu May 2026 | 180.33 | 179.20 to 189.29 | -1.82% | 0.25 times |
Videos related to: SPARC NEWS why is Sun Pharma Advanced Research Company Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
